Pre-Index Continuous Variables | LABA or LAMATx | LABA and LAMA Tx | LABA, LAMA, and ICS Tx | Significant Pairwise Paired t-tests* | |||
---|---|---|---|---|---|---|---|
 | (n = 523) | (n = 523) | (n = 523) |  | |||
 | LS Mean (SE) | LS Mean (SE) | LS Mean (SE) |  | |||
Age | 70.0 | (9.4) | 70.7 | (9.4) | 70.4 | (9.3) | NONE |
Rx comorbidity score | 6.2 | (2.6) | 6.4 | (2.8) | 6.2 | (2.6) | NONE |
% Days COPD medication exposure | 64.3 | (32.3) | 66.3 | (33.8) | 63.2 | (32.8) | DvT |
Average copay amount | 12.9 | (12.4) | 13.9 | (13.4) | 14.0 | (12.4) | NONE |
Total COPD-related costs | 1,895.9 | (1914.5) | 1,987.7 | (2411.5) | 1,973.1 | (2216.6) | NONE |
Number of hospital visits | 0.2 | (0.5) | 0.2 | (0.5) | 0.2 | (0.5) | NONE |
Number of days in hospital | 0.8 | (2.5) | 0.8 | (2.3) | 0.6 | (2.3) | NONE |
Number of emergency room visits | 0.5 | (1.1) | 0.4 | (1.0) | 0.4 | (0.8) | NONE |
Number of outpatient visits | 21.7 | (16.8) | 22.4 | (16.7) | 20.9 | (18.8) | NONE |